Next Article in Journal
Book Review: Hypnotic Approaches in Cancer and Palliative Care
Previous Article in Journal
A Simple Approach for Eliminating Spam
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 23
Issue 1
10.3747/co.23.2913
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

De-Escalation of Bone-Targeted Agents for Metastatic Prostate Cancer

by
Brian Younho Hong
1,
Mohammed F.K. Ibrahim
2,
Ricardo Fernandes
2,
Sasha Mazzarello
3,
Brian Hutton
4,
Risa Shorr
5 and
Mark Clemons
6,*
1
MD Program, Faculty of Medicine University of Ottawa, Ottawa, ON, Canada
2
Division of Medical Oncology and Department of Medicine University of Ottawa, Ottawa, ON, Canada
3
Ottawa Hospital Research Institute, Ottawa, ON, Canada
4
Department of Epidemiology and Community Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada
5
The Ottawa Hospital Ottawa, Ottawa, ON, Canada
6
Division of Medical Oncology and Department of Medicine University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2016, 23(1), 77-78; https://doi.org/10.3747/co.23.2913
Submission received: 2 November 2015 / Revised: 4 December 2015 / Accepted: 6 January 2016 / Published: 1 February 2016

Abstract

Despite advances in therapy, bone remains the most common site of prostate cancer recurrence [...]

Share and Cite

MDPI and ACS Style

Hong, B.Y.; Ibrahim, M.F.K.; Fernandes, R.; Mazzarello, S.; Hutton, B.; Shorr, R.; Clemons, M. De-Escalation of Bone-Targeted Agents for Metastatic Prostate Cancer. Curr. Oncol. 2016, 23, 77-78. https://doi.org/10.3747/co.23.2913

AMA Style

Hong BY, Ibrahim MFK, Fernandes R, Mazzarello S, Hutton B, Shorr R, Clemons M. De-Escalation of Bone-Targeted Agents for Metastatic Prostate Cancer. Current Oncology. 2016; 23(1):77-78. https://doi.org/10.3747/co.23.2913

Chicago/Turabian Style

Hong, Brian Younho, Mohammed F.K. Ibrahim, Ricardo Fernandes, Sasha Mazzarello, Brian Hutton, Risa Shorr, and Mark Clemons. 2016. "De-Escalation of Bone-Targeted Agents for Metastatic Prostate Cancer" Current Oncology 23, no. 1: 77-78. https://doi.org/10.3747/co.23.2913

APA Style

Hong, B. Y., Ibrahim, M. F. K., Fernandes, R., Mazzarello, S., Hutton, B., Shorr, R., & Clemons, M. (2016). De-Escalation of Bone-Targeted Agents for Metastatic Prostate Cancer. Current Oncology, 23(1), 77-78. https://doi.org/10.3747/co.23.2913

Article Metrics

Back to TopTop